We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
(+58%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Honeywell
HON
|
+$33.2M |
| 4 |
JPMorgan Chase
JPM
|
+$32.4M |
| 5 |
CME Group
CME
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$33.3M |
| 2 |
PayPal
PYPL
|
+$33.1M |
| 3 |
Amazon
AMZN
|
+$32.1M |
| 4 |
PPG Industries
PPG
|
+$27.6M |
| 5 |
Autodesk
ADSK
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 14.63% |
| 3 | Healthcare | 13.67% |
| 4 | Financials | 11.93% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PZN
1926
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $144K | ﹤0.01% |
26,410
+13,029
| +97% | +$60.8K |
|
|
EXPR
1927
DELISTED
Express, Inc.
EXPR
| $143K | ﹤0.01% |
4,641
-27,403
| -86% | -$1.01M |
|
|
SRGA
1928
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $143K | ﹤0.01% |
1,497
-2,872
| -66% | -$214K |
|
|
CMO
1929
DELISTED
Capstead Mortgage Corp.
CMO
| $143K | ﹤0.01% |
25,992
-25,920
| -50% | -$130K |
|
1930
Murphy Oil
MUR
$5.58B
| $142K | ﹤0.01% |
+10,323
| New | +$119K |
|
|
VNE
1931
DELISTED
Veoneer, Inc.
VNE
| $142K | ﹤0.01% |
+13,259
| New | +$130K |
|
1932
Liquidia Corp
LQDA
$7.67B
| $141K | ﹤0.01% |
16,769
+4,406
| +36% | +$33.4K |
|
|
AXLA
1933
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $141K | ﹤0.01% |
+1,022
| New | +$125K |
|
|
OBSV
1934
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $141K | ﹤0.01% |
+23,905
| New | +$90.2K |
|
1935
Horizon Bancorp
HBNC
$1.03B
| $140K | ﹤0.01% |
+13,125
| New | +$134K |
|
|
DS
1936
DELISTED
Drive Shack Inc.
DS
| $139K | ﹤0.01% |
74,913
+40,707
| +119% | +$66.9K |
|
|
DNR
1937
DELISTED
Denbury Resources, Inc.
DNR
| $139K | ﹤0.01% |
+504,139
| New | +$151K |
|
|
AGEN
1938
Agenus
AGEN
$249M
| $138K | ﹤0.01% |
1,787
-325
| -15% | -$19.5K |
|
|
ARD
1939
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $138K | ﹤0.01% |
+10,711
| New | +$134K |
|
1940
AXT Inc
AXTI
$3.09B
| $137K | ﹤0.01% |
+28,776
| New | +$136K |
|
1941
Titan Machinery
TITN
$466M
| $137K | ﹤0.01% |
12,605
-49,747
| -80% | -$476K |
|
1942
iHeartMedia
IHRT
$535M
| $136K | ﹤0.01% |
+16,305
| New | +$127K |
|
|
MCF
1943
DELISTED
Contango Oil & Gas Co.
MCF
| $136K | ﹤0.01% |
59,331
+14,015
| +31% | +$34.2K |
|
1944
SandRidge Energy
SD
$510M
| $135K | ﹤0.01% |
104,748
+84,081
| +407% | +$126K |
|
1945
Ardmore Shipping
ASC
$678M
| $134K | ﹤0.01% |
30,958
-35,712
| -54% | -$191K |
|
1946
vTv Therapeutics
VTVT
$121M
| $134K | ﹤0.01% |
+1,491
| New | +$147K |
|
|
VIVS
1947
VivoSim Labs
VIVS
$1.46M
| $134K | ﹤0.01% |
+1,018
| New | +$124K |
|
1948
GameStop
GME
$9.5B
| $133K | ﹤0.01% |
122,932
-704,224
| -85% | -$813K |
|
1949
Cemex
CX
$17.4B
| $132K | ﹤0.01% |
+45,893
| New | +$108K |
|
1950
Viridian Therapeutics
VRDN
$2.13B
| $132K | ﹤0.01% |
7,942
+3,458
| +77% | +$39.3K |
|
Similar funds
Squarepoint's Q2 2020 Portfolio in Review
As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.
- Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
- Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
- Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
- Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
- Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
- Squarepoint opened 906 new positions and closed 520 in Q2 2020.
- Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.
Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.